InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Arcus Biosciences, Inc.

RCUS Clue Score44
United States Fiscal year ends December CIK 0001724521 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

49
Insider
Date
Role
Action
Shares
Price
Amount
Terry J Rosen
27 Feb 2025
Chief Executive Officer
Buy
19,800
$10.18
$201.47K
Yasunori Kaneko
27 Feb 2025
Director
Buy
20,000
$10.06
$201.20K
Gilead Sciences, Inc.
18 Feb 2025
10% owner
Buy
1,363,636
$11.00
$15.00M
Gilead Sciences, Inc.
29 Jan 2024
10% owner
Buy
15,238,095
$21.00
$320.00M
Gilead Sciences, Inc.
28 Jun 2023
10% owner
Buy
1,010,000
$19.26
$19.45M
Yasunori Kaneko
23 Apr 2021
Director
Buy
4,133
$31.37
$129.65K
Kathryn E Falberg
31 Mar 2021
Director
Buy indirect
20,000
$28.35
$567.00K
Gilead Sciences, Inc.
31 Jan 2021
10% owner
Buy
5,650,000
$39.00
$220.35M
II Robert C. Goeltz
9 Sep 2020
Chief Financial Officer
Buy
5,000
$21.57
$107.85K
Terry J Rosen
10 Aug 2020
Chief Executive Officer
Buy indirect
32,050
$23.38
$749.40K
Terry J Rosen
7 Aug 2020
Chief Executive Officer
Buy indirect
11,655
$21.44
$249.91K
William Grossman
31 Jul 2020
Chief Medical Officer
Buy
100
$19.68
$1.97K
William Grossman
31 Jul 2020
Chief Medical Officer
Buy
100
$19.77
$1.98K
William Grossman
14 Oct 2019
Chief Medical Officer
Buy
300
$8.00
$2.40K
William Grossman
10 Oct 2019
Chief Medical Officer
Buy
100
$8.00
$800.00
Juan C. Jaen
28 Jun 2019
President
Buy indirect
4,894
$7.89
$38.64K
Juan C. Jaen
27 Jun 2019
President
Buy indirect
10,106
$7.44
$75.22K
Kathryn E Falberg
13 Jun 2019
Director
Buy indirect
12,935
$8.52
$110.15K
Kathryn E Falberg
12 Jun 2019
Director
Buy indirect
10,000
$8.49
$84.93K
Kathryn E Falberg
11 Jun 2019
Director
Buy indirect
10,000
$7.90
$79.00K
Kathryn E Falberg
10 Jun 2019
Director
Buy indirect
10,000
$8.25
$82.50K
Kathryn E Falberg
7 Jun 2019
Director
Buy indirect
22,065
$7.99
$176.30K
Terry J Rosen
6 Jun 2019
Chief Executive Officer
Buy indirect
2,380
$7.95
$18.93K
Terry J Rosen
5 Jun 2019
Chief Executive Officer
Buy indirect
19,358
$7.93
$153.42K
Terry J Rosen
4 Jun 2019
Chief Executive Officer
Buy indirect
25,770
$7.75
$199.83K
Juan C. Jaen
3 Jun 2019
President
Buy indirect
10,000
$8.25
$82.49K
Terry J Rosen
3 Jun 2019
Chief Executive Officer
Buy indirect
15,770
$8.16
$128.75K
Juan C. Jaen
13 Nov 2018
President
Buy indirect
10,000
$11.80
$118.04K
Terry J Rosen
28 Aug 2018
Chief Executive Officer
Buy indirect
10,650
$15.48
$164.84K
Terry J Rosen
27 Aug 2018
Chief Executive Officer
Buy indirect
800
$14.92
$11.94K
Terry J Rosen
27 Aug 2018
Chief Executive Officer
Buy indirect
7,157
$14.48
$103.65K
Terry J Rosen
24 Aug 2018
Chief Executive Officer
Buy indirect
4,954
$13.40
$66.36K
Terry J Rosen
23 Aug 2018
Chief Executive Officer
Buy indirect
2,133
$13.50
$28.80K
Terry J Rosen
22 Aug 2018
Chief Executive Officer
Buy indirect
2,202
$13.52
$29.78K
Terry J Rosen
21 Aug 2018
Chief Executive Officer
Buy indirect
2,790
$13.20
$36.83K
Terry J Rosen
20 Aug 2018
Chief Executive Officer
Buy indirect
1,301
$13.21
$17.19K
Terry J Rosen
17 Aug 2018
Chief Executive Officer
Buy indirect
4,800
$13.27
$63.71K
Terry J Rosen
16 Aug 2018
Chief Executive Officer
Buy indirect
8,932
$12.95
$115.65K
Terry J Rosen
15 Aug 2018
Chief Executive Officer
Buy indirect
13,300
$12.57
$167.24K
Terry J Rosen
14 Aug 2018
Chief Executive Officer
Buy indirect
6,169
$12.36
$76.24K
Terry J Rosen
13 Aug 2018
Chief Executive Officer
Buy indirect
3,279
$11.75
$38.53K
Juan C. Jaen
13 Aug 2018
President
Buy indirect
3,159
$11.77
$37.17K
Terry J Rosen
10 Aug 2018
Chief Executive Officer
Buy indirect
2,550
$11.94
$30.45K
Juan C. Jaen
10 Aug 2018
President
Buy indirect
2,579
$11.94
$30.80K
Terry J Rosen
9 Aug 2018
Chief Executive Officer
Buy indirect
4,100
$11.92
$48.87K
Juan C. Jaen
9 Aug 2018
President
Buy indirect
4,262
$11.93
$50.86K
Kathryn E Falberg
19 Mar 2018
Director
Buy
30,000
$15.00
$450.00K
Terry J Rosen
19 Mar 2018
Chief Executive Officer
Buy indirect
66,666
$15.00
$999.99K
Juan C. Jaen
19 Mar 2018
President
Buy indirect
66,666
$15.00
$999.99K
Show all 202 transactions →

What was left out

Form 4 filings counted 258
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 61
Sales straight out of an exercise 5
Sales at will 85
Transactions with no price 0
Shares from compensation/vesting 20,866,287
Sales filed before the plan box existed 84
History held since 19 Mar 2018